Gene Symbol | Gene ID | Gene Info |
---|---|---|
Sox18
|
ENSMUSG00000046470.5 | SRY (sex determining region Y)-box 18 |
Sox12
|
ENSMUSG00000051817.8 | SRY (sex determining region Y)-box 12 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_152395307_152395458 | Sox12 | 2664 | 0.124993 | 0.42 | 1.3e-03 | Click! |
chr2_152395594_152395745 | Sox12 | 2377 | 0.135630 | 0.42 | 1.3e-03 | Click! |
chr2_152392926_152393168 | Sox12 | 4999 | 0.093452 | 0.35 | 9.1e-03 | Click! |
chr2_152398706_152399460 | Sox12 | 1020 | 0.312569 | -0.31 | 2.0e-02 | Click! |
chr2_152395933_152396597 | Sox12 | 1781 | 0.173924 | 0.29 | 3.2e-02 | Click! |
chr2_181673446_181673597 | Sox18 | 1881 | 0.172951 | 0.26 | 5.2e-02 | Click! |
chr2_181673628_181673779 | Sox18 | 2063 | 0.159280 | 0.16 | 2.5e-01 | Click! |
chr2_181671417_181671711 | Sox18 | 76 | 0.936726 | 0.12 | 3.8e-01 | Click! |
chr2_181673779_181673930 | Sox18 | 2214 | 0.150129 | 0.12 | 3.9e-01 | Click! |
chr2_181670474_181670625 | Sox18 | 1091 | 0.303538 | -0.11 | 4.3e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_16437769_16438174 | 13.79 |
Gm48726 |
predicted gene, 48726 |
2576 |
0.4 |
chr13_83985066_83985623 | 13.70 |
Gm4241 |
predicted gene 4241 |
2647 |
0.28 |
chr15_73021189_73021788 | 13.14 |
Trappc9 |
trafficking protein particle complex 9 |
34322 |
0.18 |
chr3_6886780_6886981 | 12.94 |
Gm22074 |
predicted gene, 22074 |
90388 |
0.09 |
chr16_63806861_63807216 | 10.02 |
Epha3 |
Eph receptor A3 |
56375 |
0.15 |
chr1_81594178_81594459 | 10.01 |
Gm6198 |
predicted gene 6198 |
36835 |
0.2 |
chr2_107935313_107935699 | 9.55 |
Gm23439 |
predicted gene, 23439 |
48867 |
0.19 |
chr2_3420278_3420597 | 9.33 |
Meig1 |
meiosis expressed gene 1 |
1308 |
0.32 |
chr3_139885937_139886924 | 9.09 |
Gm43678 |
predicted gene 43678 |
73666 |
0.11 |
chr4_30855756_30855939 | 9.09 |
Gm11920 |
predicted gene 11920 |
153312 |
0.04 |
chr7_96718538_96719200 | 9.01 |
Tenm4 |
teneurin transmembrane protein 4 |
59065 |
0.11 |
chr3_145083052_145083382 | 9.00 |
Clca2 |
chloride channel accessory 2 |
15887 |
0.18 |
chr11_32157683_32158170 | 9.00 |
Gm12109 |
predicted gene 12109 |
27079 |
0.12 |
chr7_44405306_44405805 | 8.98 |
Gm45124 |
predicted gene 45124 |
19155 |
0.06 |
chr3_11261156_11261347 | 8.66 |
Gm22547 |
predicted gene, 22547 |
106914 |
0.08 |
chr13_83744413_83744884 | 8.48 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
5785 |
0.13 |
chr17_13589870_13590228 | 8.43 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
21185 |
0.15 |
chr10_38553865_38554067 | 8.34 |
Gm22911 |
predicted gene, 22911 |
61515 |
0.14 |
chr2_132427639_132427949 | 8.25 |
4921508D12Rik |
RIKEN cDNA 4921508D12 gene |
3053 |
0.25 |
chr15_12480416_12480590 | 8.19 |
Pdzd2 |
PDZ domain containing 2 |
13056 |
0.23 |
chr6_103944408_103944702 | 8.17 |
Gm21054 |
predicted gene, 21054 |
20084 |
0.27 |
chr6_109874355_109874582 | 8.16 |
Gm44162 |
predicted gene, 44162 |
158921 |
0.04 |
chr13_84056571_84056869 | 8.02 |
Gm17750 |
predicted gene, 17750 |
8052 |
0.22 |
chr10_125961290_125962183 | 7.92 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
4432 |
0.33 |
chr8_61325702_61325988 | 7.88 |
Sh3rf1 |
SH3 domain containing ring finger 1 |
35744 |
0.13 |
chr2_137092072_137092235 | 7.83 |
Jag1 |
jagged 1 |
6204 |
0.3 |
chr13_84056961_84057458 | 7.79 |
Gm17750 |
predicted gene, 17750 |
7563 |
0.22 |
chr2_63963866_63964056 | 7.75 |
Fign |
fidgetin |
134027 |
0.06 |
chr18_44520470_44520631 | 7.73 |
Mcc |
mutated in colorectal cancers |
1034 |
0.65 |
chr2_17842081_17842232 | 7.66 |
Gm13323 |
predicted gene 13323 |
44172 |
0.16 |
chr8_23596316_23596734 | 7.49 |
Zmat4 |
zinc finger, matrin type 4 |
39494 |
0.19 |
chr4_23636552_23636896 | 7.38 |
Gm25978 |
predicted gene, 25978 |
9979 |
0.24 |
chr19_26770137_26770516 | 7.35 |
Smarca2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
165 |
0.96 |
chr7_117686198_117686394 | 7.33 |
Gm24063 |
predicted gene, 24063 |
90498 |
0.1 |
chr9_91377864_91378038 | 7.29 |
Zic4 |
zinc finger protein of the cerebellum 4 |
246 |
0.87 |
chr3_141937004_141937205 | 7.23 |
Bmpr1b |
bone morphogenetic protein receptor, type 1B |
5581 |
0.33 |
chr11_32002527_32003111 | 7.19 |
Nsg2 |
neuron specific gene family member 2 |
2317 |
0.33 |
chr12_90132535_90132958 | 7.17 |
Gm48700 |
predicted gene, 48700 |
64647 |
0.14 |
chr13_6306939_6307331 | 7.16 |
Gm35615 |
predicted gene, 35615 |
12421 |
0.23 |
chr14_100374770_100375216 | 7.13 |
Gm26367 |
predicted gene, 26367 |
43490 |
0.15 |
chr1_66320866_66321435 | 7.12 |
Map2 |
microtubule-associated protein 2 |
569 |
0.75 |
chr4_72233972_72234136 | 7.02 |
C630043F03Rik |
RIKEN cDNA C630043F03 gene |
32706 |
0.18 |
chr7_49018514_49018702 | 7.01 |
Gm45207 |
predicted gene 45207 |
43973 |
0.12 |
chrX_42360576_42360727 | 6.98 |
Gm14619 |
predicted gene 14619 |
13139 |
0.27 |
chr5_13982707_13982992 | 6.89 |
Sema3e |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E |
42427 |
0.13 |
chr14_93083221_93083444 | 6.74 |
Gm23509 |
predicted gene, 23509 |
54857 |
0.15 |
chr9_84253597_84253862 | 6.65 |
Gm26146 |
predicted gene, 26146 |
65374 |
0.12 |
chr11_14181939_14182516 | 6.56 |
4930554G24Rik |
RIKEN cDNA 4930554G24 gene |
3186 |
0.33 |
chr7_90262071_90262261 | 6.55 |
Ccdc83 |
coiled-coil domain containing 83 |
3252 |
0.2 |
chr8_45508006_45508255 | 6.53 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
212 |
0.94 |
chr10_19471691_19471921 | 6.53 |
Gm33104 |
predicted gene, 33104 |
14909 |
0.21 |
chr14_93009566_93009910 | 6.51 |
Gm48963 |
predicted gene, 48963 |
117036 |
0.06 |
chr2_48538627_48539050 | 6.50 |
Gm13481 |
predicted gene 13481 |
81593 |
0.1 |
chr8_12127510_12127825 | 6.49 |
A230072I06Rik |
RIKEN cDNA A230072I06 gene |
151152 |
0.03 |
chr6_55920513_55920755 | 6.45 |
Itprid1 |
ITPR interacting domain containing 1 |
33809 |
0.21 |
chr18_11905340_11905491 | 6.44 |
Gm49968 |
predicted gene, 49968 |
7716 |
0.22 |
chr13_83868824_83869019 | 6.44 |
2810049E08Rik |
RIKEN cDNA 2810049E08 gene |
22287 |
0.18 |
chr12_106453612_106453783 | 6.42 |
Gm3191 |
predicted gene 3191 |
5453 |
0.21 |
chr3_156904383_156904579 | 6.41 |
Gm15577 |
predicted gene 15577 |
16299 |
0.23 |
chr16_43502947_43503194 | 6.40 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
544 |
0.83 |
chr8_54956011_54956178 | 6.38 |
Gpm6a |
glycoprotein m6a |
1251 |
0.4 |
chr9_42173888_42174039 | 6.37 |
Gm39321 |
predicted gene, 39321 |
31602 |
0.14 |
chr17_55445850_55446443 | 6.36 |
St6gal2 |
beta galactoside alpha 2,6 sialyltransferase 2 |
98 |
0.98 |
chr13_52562127_52562509 | 6.35 |
Syk |
spleen tyrosine kinase |
20855 |
0.22 |
chr15_66239660_66240017 | 6.26 |
Kcnq3 |
potassium voltage-gated channel, subfamily Q, member 3 |
46213 |
0.14 |
chr13_83884765_83885152 | 6.21 |
2810049E08Rik |
RIKEN cDNA 2810049E08 gene |
6250 |
0.23 |
chr15_8865676_8865862 | 6.20 |
Gm5043 |
predicted gene 5043 |
48715 |
0.14 |
chr10_87501180_87501623 | 6.12 |
Gm48120 |
predicted gene, 48120 |
6461 |
0.19 |
chr1_68046813_68046988 | 6.09 |
Gm15671 |
predicted gene 15671 |
22657 |
0.22 |
chr2_54265163_54265368 | 6.07 |
Gm14035 |
predicted gene 14035 |
18850 |
0.21 |
chr11_68274100_68274260 | 6.04 |
Gm12305 |
predicted gene 12305 |
3301 |
0.28 |
chr4_25409420_25409571 | 6.03 |
Gm11894 |
predicted gene 11894 |
9854 |
0.22 |
chr4_110290181_110290407 | 6.00 |
Elavl4 |
ELAV like RNA binding protein 4 |
22 |
0.99 |
chr13_39523344_39523523 | 6.00 |
Gm47351 |
predicted gene, 47351 |
9670 |
0.2 |
chr16_21665246_21665397 | 5.90 |
2510009E07Rik |
RIKEN cDNA 2510009E07 gene |
27910 |
0.17 |
chr18_46112843_46113169 | 5.88 |
Gm38337 |
predicted gene, 38337 |
253 |
0.94 |
chrX_16910312_16910501 | 5.87 |
Ndp |
Norrie disease (pseudoglioma) (human) |
1368 |
0.59 |
chr15_44753706_44753862 | 5.86 |
Sybu |
syntabulin (syntaxin-interacting) |
1326 |
0.39 |
chr16_16559483_16559649 | 5.83 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
424 |
0.84 |
chr16_29719863_29720466 | 5.81 |
Gm49636 |
predicted gene, 49636 |
34148 |
0.18 |
chr11_112501711_112502406 | 5.77 |
BC006965 |
cDNA sequence BC006965 |
167340 |
0.04 |
chr18_19603967_19604152 | 5.70 |
Gm7720 |
predicted gene 7720 |
49099 |
0.19 |
chr12_69907639_69908007 | 5.63 |
Atl1 |
atlastin GTPase 1 |
91 |
0.95 |
chr4_122998402_122999232 | 5.63 |
Mycl |
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived |
63 |
0.96 |
chr5_149495653_149495848 | 5.63 |
Gm2566 |
predicted gene 2566 |
7302 |
0.14 |
chr7_73222985_73223145 | 5.62 |
Gm30075 |
predicted gene, 30075 |
15466 |
0.16 |
chr1_94503721_94503899 | 5.61 |
Gm7895 |
predicted gene 7895 |
33923 |
0.23 |
chr14_24617341_24617911 | 5.60 |
4930428N03Rik |
RIKEN cDNA 4930428N03 gene |
58 |
0.64 |
chr1_50647049_50647200 | 5.60 |
Gm20118 |
predicted gene, 20118 |
114094 |
0.07 |
chr4_25408022_25408173 | 5.60 |
Gm11894 |
predicted gene 11894 |
11252 |
0.22 |
chr14_122474429_122474660 | 5.58 |
2610035F20Rik |
RIKEN cDNA 2610035F20 gene |
655 |
0.44 |
chr10_17074449_17074835 | 5.58 |
Gm20125 |
predicted gene, 20125 |
11651 |
0.26 |
chr12_49945023_49945183 | 5.57 |
Gm7481 |
predicted gene 7481 |
103352 |
0.08 |
chr19_36534720_36535517 | 5.56 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
19521 |
0.2 |
chr16_42546761_42546948 | 5.55 |
Gm49739 |
predicted gene, 49739 |
117072 |
0.06 |
chr2_22029112_22029317 | 5.54 |
Gm13337 |
predicted gene 13337 |
38612 |
0.22 |
chr16_66769044_66769245 | 5.52 |
1700010K23Rik |
RIKEN cDNA 1700010K23 gene |
112026 |
0.07 |
chr3_79416895_79417312 | 5.50 |
Fnip2 |
folliculin interacting protein 2 |
49102 |
0.13 |
chr1_77629974_77630266 | 5.49 |
Gm28385 |
predicted gene 28385 |
59448 |
0.14 |
chr13_42709847_42710338 | 5.47 |
Phactr1 |
phosphatase and actin regulator 1 |
511 |
0.85 |
chr13_84067027_84067215 | 5.47 |
Gm17750 |
predicted gene, 17750 |
2349 |
0.33 |
chr1_98048208_98048425 | 5.47 |
B230216N24Rik |
RIKEN cDNA B230216N24 gene |
523 |
0.7 |
chr2_179481364_179481534 | 5.47 |
Cdh4 |
cadherin 4 |
37216 |
0.18 |
chrX_16894423_16894771 | 5.45 |
Ndp |
Norrie disease (pseudoglioma) (human) |
17177 |
0.27 |
chr14_103613671_103614004 | 5.45 |
Slain1 |
SLAIN motif family, member 1 |
36391 |
0.16 |
chr9_60266568_60266781 | 5.43 |
2010001M07Rik |
RIKEN cDNA 2010001M07 gene |
67468 |
0.11 |
chr4_31320858_31321026 | 5.42 |
Gm11922 |
predicted gene 11922 |
59530 |
0.16 |
chr12_118661557_118661934 | 5.41 |
Gm9267 |
predicted gene 9267 |
59068 |
0.12 |
chr13_84571624_84571828 | 5.40 |
Gm26913 |
predicted gene, 26913 |
119215 |
0.06 |
chr18_25378079_25378424 | 5.40 |
Gm16558 |
predicted gene 16558 |
13550 |
0.27 |
chr10_34508631_34508935 | 5.39 |
Frk |
fyn-related kinase |
25251 |
0.21 |
chr14_59737148_59737645 | 5.36 |
Gm19716 |
predicted gene, 19716 |
94848 |
0.07 |
chr7_39588137_39588315 | 5.36 |
Gm2058 |
predicted gene 2058 |
705 |
0.58 |
chr7_91582410_91582561 | 5.30 |
Gm44675 |
predicted gene 44675 |
18118 |
0.13 |
chr10_52742737_52743261 | 5.27 |
Gm47624 |
predicted gene, 47624 |
49161 |
0.11 |
chr8_61309392_61309892 | 5.26 |
1700001D01Rik |
RIKEN cDNA 1700001D01 gene |
20770 |
0.18 |
chr1_165834309_165834656 | 5.25 |
Gm32999 |
predicted gene, 32999 |
10126 |
0.1 |
chr7_75983169_75983876 | 5.24 |
Gm45139 |
predicted gene 45139 |
17302 |
0.24 |
chr14_64533719_64533870 | 5.23 |
Gm47202 |
predicted gene, 47202 |
3744 |
0.24 |
chr4_24669747_24669918 | 5.22 |
Klhl32 |
kelch-like 32 |
5595 |
0.3 |
chr18_64889548_64889699 | 5.20 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
594 |
0.63 |
chr10_30980268_30980660 | 5.17 |
Gm24168 |
predicted gene, 24168 |
37979 |
0.16 |
chr18_31449249_31449400 | 5.17 |
Syt4 |
synaptotagmin IV |
1918 |
0.29 |
chr17_13590938_13591623 | 5.14 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
22416 |
0.14 |
chr4_70810746_70810927 | 5.14 |
Gm11227 |
predicted gene 11227 |
261837 |
0.02 |
chr3_157321061_157321436 | 5.13 |
Gm22458 |
predicted gene, 22458 |
44750 |
0.14 |
chr2_131847315_131847793 | 5.11 |
5330413P13Rik |
RIKEN cDNA 5330413P13 gene |
69 |
0.93 |
chr2_57378242_57378425 | 5.10 |
Gm13531 |
predicted gene 13531 |
47376 |
0.15 |
chr8_54836396_54836562 | 5.05 |
n-R5s98 |
nuclear encoded rRNA 5S 98 |
29782 |
0.18 |
chr19_33299773_33299924 | 5.04 |
Rnls |
renalase, FAD-dependent amine oxidase |
92417 |
0.07 |
chr8_3493298_3493991 | 5.04 |
Zfp358 |
zinc finger protein 358 |
474 |
0.67 |
chr7_87925914_87926440 | 5.03 |
Gm44927 |
predicted gene 44927 |
35428 |
0.2 |
chr18_16703519_16704021 | 5.01 |
Gm15485 |
predicted gene 15485 |
24963 |
0.21 |
chr16_77291582_77292053 | 4.98 |
Gm31258 |
predicted gene, 31258 |
13743 |
0.19 |
chr8_47242449_47242654 | 4.98 |
Stox2 |
storkhead box 2 |
135 |
0.97 |
chr3_20986980_20987301 | 4.97 |
Gm7488 |
predicted gene 7488 |
62425 |
0.13 |
chr14_21252622_21252979 | 4.97 |
Adk |
adenosine kinase |
65325 |
0.13 |
chr10_90709113_90709298 | 4.95 |
Gm47591 |
predicted gene, 47591 |
19755 |
0.19 |
chr10_30980750_30980928 | 4.94 |
Gm24168 |
predicted gene, 24168 |
38354 |
0.16 |
chr2_137808272_137808679 | 4.93 |
Gm14062 |
predicted gene 14062 |
68356 |
0.14 |
chr2_106822641_106822960 | 4.93 |
Gm22813 |
predicted gene, 22813 |
13464 |
0.23 |
chr13_94317002_94317183 | 4.93 |
Gm5668 |
predicted gene 5668 |
17233 |
0.13 |
chr13_84343319_84343470 | 4.92 |
Gm26927 |
predicted gene, 26927 |
3281 |
0.29 |
chr6_22675181_22675332 | 4.91 |
Gm8927 |
predicted gene 8927 |
28180 |
0.16 |
chr10_17331363_17331552 | 4.90 |
Gm47760 |
predicted gene, 47760 |
1420 |
0.48 |
chr14_79917350_79917514 | 4.87 |
Gm49542 |
predicted gene, 49542 |
18965 |
0.15 |
chr17_63172503_63172694 | 4.86 |
Gm24730 |
predicted gene, 24730 |
30140 |
0.21 |
chr10_92162409_92163019 | 4.86 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
47 |
0.98 |
chr8_96277469_96277920 | 4.86 |
Gm32005 |
predicted gene, 32005 |
31825 |
0.19 |
chr10_113874824_113874975 | 4.84 |
Gm38333 |
predicted gene, 38333 |
121748 |
0.06 |
chr1_147187366_147187538 | 4.84 |
Gm9931 |
predicted gene 9931 |
94490 |
0.09 |
chr13_78581852_78582016 | 4.83 |
Gm48402 |
predicted gene, 48402 |
56083 |
0.14 |
chr13_88821410_88822253 | 4.81 |
Edil3 |
EGF-like repeats and discoidin I-like domains 3 |
189 |
0.97 |
chr4_3067329_3068553 | 4.81 |
Gm27878 |
predicted gene, 27878 |
16122 |
0.2 |
chr16_25660958_25661109 | 4.79 |
Trp63 |
transformation related protein 63 |
22730 |
0.21 |
chr1_42539688_42540042 | 4.79 |
Gm37047 |
predicted gene, 37047 |
48052 |
0.15 |
chr3_4546148_4546485 | 4.77 |
Gm22944 |
predicted gene, 22944 |
21019 |
0.21 |
chr2_105719588_105719763 | 4.76 |
Gm13954 |
predicted gene 13954 |
10676 |
0.18 |
chr13_34133057_34133249 | 4.76 |
Gm36500 |
predicted gene, 36500 |
707 |
0.51 |
chr9_90693284_90693632 | 4.76 |
Gm2497 |
predicted gene 2497 |
40066 |
0.15 |
chr6_15408025_15408409 | 4.75 |
Gm25470 |
predicted gene, 25470 |
3236 |
0.33 |
chr1_57082980_57083131 | 4.73 |
9130024F11Rik |
RIKEN cDNA 9130024F11 gene |
42662 |
0.14 |
chr5_149440136_149440665 | 4.73 |
Tex26 |
testis expressed 26 |
681 |
0.48 |
chr1_96346717_96347057 | 4.72 |
Gm37076 |
predicted gene, 37076 |
33645 |
0.18 |
chr2_101173133_101173284 | 4.72 |
Gm20693 |
predicted gene 20693 |
397416 |
0.01 |
chr9_36821327_36821662 | 4.72 |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
370 |
0.82 |
chr2_93957591_93957803 | 4.71 |
Gm13889 |
predicted gene 13889 |
496 |
0.74 |
chr18_47703511_47703841 | 4.69 |
Gm5236 |
predicted gene 5236 |
26091 |
0.18 |
chr8_28602186_28602351 | 4.69 |
Gm26795 |
predicted gene, 26795 |
8736 |
0.28 |
chr13_83749344_83749514 | 4.69 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
10566 |
0.12 |
chr4_65838866_65839193 | 4.68 |
Trim32 |
tripartite motif-containing 32 |
233780 |
0.02 |
chr18_54452393_54453295 | 4.68 |
Gm50361 |
predicted gene, 50361 |
23921 |
0.19 |
chr18_69563166_69563317 | 4.67 |
Tcf4 |
transcription factor 4 |
94 |
0.98 |
chr6_73497578_73497729 | 4.67 |
1700065L07Rik |
RIKEN cDNA 1700065L07 gene |
26632 |
0.15 |
chr7_91208818_91209022 | 4.66 |
Gm24552 |
predicted gene, 24552 |
34075 |
0.14 |
chr2_50971005_50971315 | 4.66 |
Gm13498 |
predicted gene 13498 |
61476 |
0.15 |
chr2_63117689_63117870 | 4.64 |
Kcnh7 |
potassium voltage-gated channel, subfamily H (eag-related), member 7 |
66391 |
0.14 |
chr8_103314608_103315058 | 4.63 |
1600027J07Rik |
RIKEN cDNA 1600027J07 gene |
32701 |
0.2 |
chr11_39733776_39733988 | 4.63 |
Gm12131 |
predicted gene 12131 |
6170 |
0.33 |
chr18_45008774_45008950 | 4.62 |
Gm31706 |
predicted gene, 31706 |
36000 |
0.15 |
chrX_135101617_135101982 | 4.62 |
Gm6207 |
predicted gene 6207 |
21185 |
0.14 |
chr13_34575671_34575928 | 4.62 |
Gm36758 |
predicted gene, 36758 |
13813 |
0.16 |
chr16_40640068_40640219 | 4.61 |
Gm27887 |
predicted gene, 27887 |
272206 |
0.02 |
chr4_110050502_110051534 | 4.60 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
72965 |
0.11 |
chr5_21732375_21732598 | 4.58 |
Pmpcb |
peptidase (mitochondrial processing) beta |
4655 |
0.15 |
chr17_65700141_65700311 | 4.58 |
Gm49867 |
predicted gene, 49867 |
38648 |
0.13 |
chr13_69260577_69260855 | 4.58 |
Gm4812 |
predicted gene 4812 |
84939 |
0.08 |
chr13_84569455_84569857 | 4.57 |
Gm26913 |
predicted gene, 26913 |
121285 |
0.06 |
chr5_46160925_46161076 | 4.57 |
4930405L22Rik |
RIKEN cDNA 4930405L22 gene |
228591 |
0.02 |
chr6_145585388_145585553 | 4.55 |
Lmntd1 |
lamin tail domain containing 1 |
28499 |
0.17 |
chr3_115856630_115856858 | 4.54 |
Dph5 |
diphthamide biosynthesis 5 |
31093 |
0.11 |
chr14_103763556_103763746 | 4.54 |
Slain1os |
SLAIN motif family, member 1, opposite strand |
64209 |
0.11 |
chr2_80398810_80399023 | 4.54 |
Gm13752 |
predicted gene 13752 |
4019 |
0.23 |
chr7_62416271_62416450 | 4.53 |
Mkrn3 |
makorin, ring finger protein, 3 |
3779 |
0.19 |
chr8_12947304_12948554 | 4.50 |
Mcf2l |
mcf.2 transforming sequence-like |
10 |
0.49 |
chr8_89324930_89325098 | 4.50 |
Gm5356 |
predicted pseudogene 5356 |
137454 |
0.05 |
chr12_45466153_45466321 | 4.48 |
Gm33680 |
predicted gene, 33680 |
36 |
0.98 |
chr5_46830784_46831330 | 4.48 |
Gm43092 |
predicted gene 43092 |
36377 |
0.24 |
chr3_139023701_139023892 | 4.46 |
Rap1gds1 |
RAP1, GTP-GDP dissociation stimulator 1 |
39259 |
0.16 |
chr13_29015675_29016011 | 4.46 |
A330102I10Rik |
RIKEN cDNA A330102I10 gene |
450 |
0.87 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.3 | 13.0 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.2 | 9.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.8 | 8.9 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
1.7 | 5.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.7 | 5.0 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
1.7 | 5.0 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
1.6 | 6.3 | GO:0030035 | microspike assembly(GO:0030035) |
1.5 | 5.9 | GO:0007412 | axon target recognition(GO:0007412) |
1.4 | 4.2 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.3 | 5.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.3 | 2.5 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
1.3 | 3.8 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.3 | 3.8 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.2 | 3.7 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.2 | 3.7 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
1.2 | 10.7 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.2 | 3.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.1 | 2.2 | GO:0060166 | olfactory pit development(GO:0060166) |
1.1 | 10.0 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.0 | 12.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.0 | 6.0 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.0 | 4.0 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.9 | 2.8 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.9 | 2.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.9 | 0.9 | GO:0048880 | sensory system development(GO:0048880) |
0.9 | 3.6 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.9 | 2.7 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.9 | 1.8 | GO:0021564 | vagus nerve development(GO:0021564) |
0.9 | 5.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.9 | 3.5 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.9 | 3.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.9 | 3.4 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.8 | 4.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.8 | 2.4 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.8 | 2.4 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.8 | 2.4 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.8 | 2.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.8 | 2.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.8 | 3.9 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.8 | 2.3 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.8 | 2.3 | GO:0030070 | insulin processing(GO:0030070) |
0.8 | 2.3 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.7 | 12.7 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.7 | 3.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.7 | 2.2 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.7 | 2.9 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.7 | 3.6 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.7 | 2.8 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.7 | 2.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.7 | 2.7 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.7 | 3.4 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.7 | 3.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.7 | 2.0 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.6 | 0.6 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.6 | 0.6 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.6 | 1.9 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.6 | 2.6 | GO:0001927 | exocyst assembly(GO:0001927) |
0.6 | 2.5 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.6 | 1.9 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.6 | 1.2 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.6 | 2.4 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.6 | 6.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.6 | 2.4 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.6 | 1.8 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.6 | 1.7 | GO:0060594 | mammary gland specification(GO:0060594) |
0.6 | 2.3 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.6 | 0.6 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.6 | 1.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.6 | 1.1 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.6 | 1.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.6 | 1.7 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.5 | 1.6 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.5 | 1.6 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.5 | 1.1 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.5 | 1.6 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.5 | 3.2 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.5 | 2.1 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.5 | 1.6 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.5 | 0.5 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.5 | 2.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.5 | 2.1 | GO:0060437 | lung growth(GO:0060437) |
0.5 | 1.6 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.5 | 2.6 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.5 | 2.6 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.5 | 1.6 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.5 | 1.5 | GO:0048840 | otolith development(GO:0048840) |
0.5 | 1.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.5 | 6.6 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.5 | 5.6 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.5 | 1.5 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.5 | 8.6 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.5 | 2.0 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.5 | 2.0 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.5 | 5.0 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.5 | 2.0 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.5 | 1.9 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.5 | 1.5 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.5 | 1.4 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.5 | 5.2 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.5 | 1.4 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.5 | 0.5 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.5 | 1.4 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.5 | 3.7 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.5 | 6.4 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.5 | 2.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.4 | 4.9 | GO:0060384 | innervation(GO:0060384) |
0.4 | 1.8 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.4 | 0.4 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.4 | 1.7 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.4 | 1.3 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.4 | 1.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.4 | 0.9 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.4 | 0.9 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.4 | 0.9 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.4 | 2.6 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.4 | 0.4 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.4 | 1.3 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.4 | 1.3 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.4 | 2.0 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.4 | 0.4 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.4 | 1.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 1.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.4 | 1.6 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.4 | 3.6 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.4 | 7.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.4 | 5.9 | GO:0010842 | retina layer formation(GO:0010842) |
0.4 | 0.4 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.4 | 1.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.4 | 1.6 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.4 | 2.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.4 | 1.5 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.4 | 1.9 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.4 | 1.1 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.4 | 0.7 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.4 | 1.5 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.4 | 1.1 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.4 | 0.4 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.4 | 0.4 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.4 | 3.7 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.4 | 7.3 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.4 | 0.7 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.4 | 1.4 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.3 | 1.4 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.3 | 1.4 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.3 | 1.0 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.3 | 1.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 0.7 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.3 | 1.0 | GO:0009139 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.3 | 1.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.3 | 1.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.3 | 1.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.3 | 1.7 | GO:0015808 | L-alanine transport(GO:0015808) |
0.3 | 0.7 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.3 | 1.3 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.3 | 1.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.3 | 1.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 0.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.3 | 0.6 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.3 | 1.6 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.3 | 1.6 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.3 | 0.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.3 | 0.6 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 1.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.3 | 1.8 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.3 | 0.9 | GO:0021756 | striatum development(GO:0021756) |
0.3 | 1.8 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.3 | 0.6 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.3 | 0.3 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.3 | 3.2 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.3 | 0.6 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 1.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.3 | 1.5 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.3 | 1.5 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.3 | 0.9 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.3 | 0.3 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.3 | 0.6 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.3 | 0.6 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.3 | 2.0 | GO:0071625 | vocalization behavior(GO:0071625) |
0.3 | 2.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.3 | 0.3 | GO:0046959 | nonassociative learning(GO:0046958) habituation(GO:0046959) |
0.3 | 1.1 | GO:0035510 | DNA dealkylation(GO:0035510) DNA demethylation(GO:0080111) |
0.3 | 0.3 | GO:0061743 | motor learning(GO:0061743) |
0.3 | 1.1 | GO:1902669 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.3 | 0.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 0.8 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.3 | 1.9 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.3 | 1.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.3 | 1.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.3 | 0.5 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.3 | 0.3 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.3 | 0.5 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.3 | 1.6 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.3 | 0.3 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.3 | 13.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 0.5 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.3 | 0.8 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.3 | 0.3 | GO:0035106 | operant conditioning(GO:0035106) |
0.3 | 0.8 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 0.8 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.3 | 1.0 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
0.3 | 2.8 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.3 | 2.3 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.3 | 1.8 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.3 | 0.5 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.3 | 5.0 | GO:0001964 | startle response(GO:0001964) |
0.3 | 1.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.3 | 2.0 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.2 | 0.7 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.2 | 1.5 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 0.7 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.2 | 1.0 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.2 | 2.9 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.2 | 0.7 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.2 | 0.7 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 0.5 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 0.7 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.2 | 1.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 0.2 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.2 | 2.1 | GO:0060579 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.2 | 1.2 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.2 | 0.7 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.2 | 0.7 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.2 | 0.7 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.2 | 1.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 1.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 0.7 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 0.2 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.2 | 1.8 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 0.9 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.2 | 1.1 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.2 | 0.7 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 1.5 | GO:0008038 | neuron recognition(GO:0008038) |
0.2 | 0.8 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.2 | 0.4 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.2 | 0.6 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.2 | 0.4 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.2 | 0.4 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.2 | 0.2 | GO:0072162 | metanephric mesenchymal cell differentiation(GO:0072162) |
0.2 | 0.8 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.2 | 0.4 | GO:0090427 | activation of meiosis(GO:0090427) |
0.2 | 0.8 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 0.8 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 2.3 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 0.2 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.2 | 0.8 | GO:0021544 | subpallium development(GO:0021544) |
0.2 | 0.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.2 | 0.4 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.2 | 0.8 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.2 | 0.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.2 | 0.8 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.2 | 0.4 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.2 | 0.6 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.2 | 0.2 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.2 | 2.4 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.2 | 0.4 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.2 | 0.7 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 1.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.2 | 2.7 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.2 | 0.5 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 0.7 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.2 | 0.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.2 | 0.5 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 1.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.3 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.2 | 1.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.2 | 0.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.2 | 0.2 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.2 | 0.7 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.2 | 4.7 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.2 | 0.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 1.2 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.2 | 0.7 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 0.5 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.2 | 0.5 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.2 | 0.5 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 0.2 | GO:0042891 | antibiotic transport(GO:0042891) |
0.2 | 1.0 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.2 | 0.7 | GO:0015867 | ATP transport(GO:0015867) |
0.2 | 0.8 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.2 | 0.5 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 1.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 0.6 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.2 | 1.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 2.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.9 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.2 | 0.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 0.5 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.2 | 0.2 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.2 | 0.2 | GO:0035483 | gastric emptying(GO:0035483) |
0.1 | 0.6 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 3.6 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.1 | 1.2 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.1 | 0.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 1.0 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.1 | 0.4 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 1.0 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.4 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 0.6 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 0.6 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
0.1 | 0.3 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.4 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.1 | 2.5 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.1 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.1 | 0.9 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.1 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.1 | 0.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 1.1 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.6 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.8 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.4 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.1 | 0.5 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.1 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.1 | 0.4 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.1 | 0.8 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.4 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 0.4 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 1.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 1.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.6 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.4 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.3 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.1 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.4 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 0.4 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 0.2 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.2 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.1 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.1 | GO:0045472 | response to ether(GO:0045472) |
0.1 | 0.4 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.1 | 0.1 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.1 | 0.5 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.1 | 0.2 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.1 | 0.1 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.1 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.1 | 0.9 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 3.2 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.1 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 0.8 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.1 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.1 | 0.8 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.5 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 2.5 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.3 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.7 | GO:0001975 | response to amphetamine(GO:0001975) |
0.1 | 0.4 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.2 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.1 | 0.3 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.1 | 0.1 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.1 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.2 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.1 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.5 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 0.2 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 0.5 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.4 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 2.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.5 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.7 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.4 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.3 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 0.4 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.3 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.1 | 1.1 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 0.9 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.1 | 0.6 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.2 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.3 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.1 | 0.2 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 0.3 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 0.4 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.1 | 1.4 | GO:0003407 | neural retina development(GO:0003407) |
0.1 | 0.2 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.1 | 0.4 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 0.2 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.1 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.1 | 0.3 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.3 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.1 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.1 | 0.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.4 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.5 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.4 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.6 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 0.5 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.3 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.3 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.1 | 1.5 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.3 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 0.3 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.2 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.2 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.1 | 0.3 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.1 | 1.0 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.1 | 0.7 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.1 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.1 | 0.3 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.3 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.2 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 1.3 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.3 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.1 | 0.2 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.1 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.7 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.1 | 0.1 | GO:0006971 | hypotonic response(GO:0006971) cellular hypotonic response(GO:0071476) |
0.1 | 0.2 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.2 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.1 | 0.3 | GO:0060044 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.1 | 0.2 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.1 | 0.8 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.2 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 0.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.2 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.1 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.4 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.3 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.1 | 0.4 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.2 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.4 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.1 | 0.4 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.4 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 0.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.2 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 0.2 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.1 | 0.2 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.1 | 0.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.3 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.1 | 0.1 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.1 | 0.2 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 1.8 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 0.1 | GO:0098739 | import across plasma membrane(GO:0098739) |
0.1 | 0.8 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.1 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.1 | 0.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.1 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.1 | 0.2 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.1 | 0.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.7 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.4 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.3 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 1.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.4 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.1 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 0.3 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.1 | 0.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 0.1 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.1 | GO:0072172 | mesonephric tubule formation(GO:0072172) |
0.1 | 0.2 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.1 | 1.1 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.1 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.5 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.1 | 0.4 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.1 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 1.2 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.1 | 0.2 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.1 | 0.3 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.2 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.1 | 0.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 0.6 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.1 | 0.2 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.1 | 0.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 1.9 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.1 | 0.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.1 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.1 | 0.6 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 0.4 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.1 | 0.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.1 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.0 | 0.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.2 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.1 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.0 | 0.4 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.2 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.0 | 0.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.0 | 0.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.0 | 0.2 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 0.0 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.0 | 0.0 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.0 | 0.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.0 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.0 | 0.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.0 | 0.1 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.0 | 0.0 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
0.0 | 0.3 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.0 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.0 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.0 | 0.0 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.0 | 0.2 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.0 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.0 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.0 | 0.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.0 | 0.2 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.1 | GO:0060399 | regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 | 0.6 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.2 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.3 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.0 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 0.3 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.0 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.0 | 0.1 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.0 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
0.0 | 0.0 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.0 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.0 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.0 | 0.1 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.0 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.1 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.0 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.1 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.0 | 0.1 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.0 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.2 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.0 | 0.1 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.0 | 0.1 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.0 | 0.1 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.0 | GO:0035850 | epithelial cell differentiation involved in kidney development(GO:0035850) |
0.0 | 0.1 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.0 | 0.2 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 0.4 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.0 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.0 | 0.1 | GO:0002786 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
0.0 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.0 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
0.0 | 0.3 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.0 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.0 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.0 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.0 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.7 | GO:0099531 | presynaptic process involved in chemical synaptic transmission(GO:0099531) |
0.0 | 0.0 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.1 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.0 | 0.0 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.3 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.0 | 0.1 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.0 | 0.0 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.0 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.0 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.0 | 0.4 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.0 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.1 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.0 | 0.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.0 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 1.4 | GO:0007626 | locomotory behavior(GO:0007626) |
0.0 | 0.0 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.0 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.0 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.0 | 0.0 | GO:0086016 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
0.0 | 0.0 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.0 | 0.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 0.0 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.0 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.0 | 0.0 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.0 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.0 | 0.0 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.0 | 0.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.0 | 0.0 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 12.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.1 | 3.4 | GO:0072534 | perineuronal net(GO:0072534) |
1.1 | 4.3 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.8 | 3.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.8 | 5.3 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.8 | 7.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.8 | 3.0 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.7 | 5.7 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.7 | 3.4 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.7 | 7.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.6 | 3.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.6 | 5.0 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.6 | 2.3 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.5 | 4.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.5 | 2.0 | GO:0042583 | chromaffin granule(GO:0042583) |
0.5 | 2.5 | GO:0071547 | piP-body(GO:0071547) |
0.5 | 6.1 | GO:0043194 | axon initial segment(GO:0043194) |
0.5 | 4.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.5 | 1.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.5 | 1.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.4 | 2.6 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.4 | 2.1 | GO:0097433 | dense body(GO:0097433) |
0.4 | 6.9 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.4 | 2.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 5.8 | GO:0031527 | filopodium membrane(GO:0031527) |
0.4 | 1.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 1.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.4 | 1.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 5.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 9.3 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 4.4 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.3 | 1.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.3 | 1.0 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.3 | 1.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.3 | 1.6 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.3 | 2.5 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 2.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 14.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 0.9 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.3 | 0.6 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.3 | 3.4 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.3 | 2.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.3 | 3.9 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 0.8 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 7.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 0.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 1.7 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 0.6 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 2.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.8 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 0.9 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 1.5 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.2 | 4.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.2 | 1.2 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 1.5 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 0.5 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 1.9 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 1.0 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 1.3 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 1.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 1.2 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.8 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.8 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 18.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 1.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 0.1 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 1.7 | GO:0043205 | fibril(GO:0043205) |
0.1 | 6.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.3 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.3 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 0.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 2.4 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.7 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 1.4 | GO:0044298 | cell body membrane(GO:0044298) |
0.1 | 0.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.2 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.8 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 1.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.3 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.3 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 0.3 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 6.4 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 3.0 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.6 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.2 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.2 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 0.4 | GO:0005688 | U6 snRNP(GO:0005688) |
0.0 | 1.7 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 2.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 0.3 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.4 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.2 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.5 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.0 | 0.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.2 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.1 | GO:0097449 | astrocyte projection(GO:0097449) |
0.0 | 0.0 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.3 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.1 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 13.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.6 | 7.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.3 | 6.8 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.9 | 9.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.8 | 7.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.6 | 9.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.4 | 9.7 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.4 | 4.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.1 | 3.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.0 | 3.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.0 | 5.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.9 | 3.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.9 | 3.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.8 | 1.6 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.7 | 2.9 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.7 | 3.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.6 | 1.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.6 | 3.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.6 | 5.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.6 | 1.9 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.6 | 3.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.6 | 1.8 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.6 | 2.9 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.6 | 5.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.6 | 2.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.6 | 2.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.5 | 2.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.5 | 1.6 | GO:0035939 | microsatellite binding(GO:0035939) |
0.5 | 2.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.5 | 1.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.5 | 1.5 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.5 | 4.1 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.5 | 1.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.5 | 3.9 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.5 | 3.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.5 | 3.2 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.5 | 1.4 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.5 | 2.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.4 | 1.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.4 | 2.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 1.6 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.4 | 0.8 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.4 | 2.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.4 | 0.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.4 | 0.4 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.4 | 4.1 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.4 | 3.0 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.4 | 5.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.4 | 1.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.4 | 2.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.3 | 1.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 0.7 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 1.0 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.3 | 1.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.3 | 1.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 1.6 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.3 | 3.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 1.8 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.3 | 1.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 1.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.3 | 0.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.3 | 1.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.3 | 0.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.3 | 0.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.3 | 0.8 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.3 | 1.1 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 0.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 2.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 0.8 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.3 | 4.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 0.5 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 0.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 1.5 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.2 | 1.2 | GO:0005165 | neurotrophin receptor binding(GO:0005165) neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 0.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 0.7 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 1.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 0.5 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.2 | 1.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 2.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 4.1 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 1.4 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.2 | 0.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 0.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 0.7 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 2.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 0.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 0.9 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.2 | 4.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 2.5 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 0.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.2 | 0.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 2.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 1.8 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.2 | 0.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 5.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 0.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 1.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 0.8 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 2.2 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.2 | 1.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 1.6 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.2 | 1.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.7 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 0.9 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 0.9 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 0.8 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.2 | 0.2 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.2 | 0.5 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.2 | 1.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 1.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 0.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 0.5 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.2 | 0.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 0.5 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 2.9 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.2 | 2.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 1.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.1 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 5.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.9 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 1.4 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 3.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.4 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.8 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.8 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 4.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 1.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.4 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.1 | 2.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 3.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 3.6 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 1.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 1.5 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 3.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 2.7 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 2.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 2.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.5 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.3 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.5 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 1.0 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 3.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 1.1 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.1 | 0.3 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 2.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.9 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.6 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 1.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.3 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 0.3 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 5.3 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.1 | 2.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.4 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.6 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.6 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 1.1 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 1.9 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 0.1 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.1 | 1.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 1.4 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 0.4 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.9 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.6 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 1.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.9 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.5 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.1 | GO:0034562 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 0.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 1.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.1 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.2 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.1 | 0.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.6 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.3 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 0.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.2 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 1.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.2 | GO:0048045 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.1 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.9 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.5 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.0 | 0.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.6 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.1 | GO:0048763 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
0.0 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.5 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.2 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 1.1 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.0 | GO:0000701 | purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) |
0.0 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.1 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.0 | 0.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.0 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 0.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.0 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.2 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.0 | 0.1 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.2 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.1 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.0 | 0.6 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.0 | 0.1 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.0 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.0 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.5 | GO:0044823 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.0 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.3 | 4.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 0.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 6.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 2.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 6.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 3.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 7.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 5.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 2.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 3.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 4.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 1.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 1.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 1.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 1.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.8 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 11.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 8.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.7 | 8.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.6 | 0.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.5 | 5.7 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.5 | 11.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 4.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 3.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 0.6 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.3 | 4.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 7.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 1.1 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.3 | 1.8 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 2.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 2.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 2.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 1.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 1.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 2.6 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.2 | 3.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 0.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 1.6 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.2 | 2.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 3.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.2 | 0.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 0.2 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.2 | 3.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 6.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 1.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 2.5 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 0.7 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.1 | 0.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 2.6 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 1.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.8 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 2.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 2.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 3.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.1 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.1 | 0.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 1.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.7 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 0.2 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.1 | 0.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 1.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 0.4 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 1.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 0.0 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.0 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |